Medrio and PHASTAR Unite to Offer Data Visualization for Clinical Trials


Medrio, Inc. and PHASTAR announced that they have partnered aiming to leverage metadata surrounding electronic patient-reported outcomes (ePRO) for advanced data visualization, providing insight into patient compliance and burden.

PHASTAR ran a pilot with 33 volunteers completing EQ-5D, a health-related measure of quality-of-life questionnaire, to understand how metadata may be used effectively to monitor ePRO data collection during a study.

The PHASTAR team used Medrio ePRO for initial data collection and Medrio’s Export API to funnel the ePRO and metadata into PHASTAR’s data visualization tool, PHIZUAL.

For more click here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.